Stimulating osteosarcoma cells with an FAK inhibitor or c-Src inhibitor (PP2) eliminated VCAM-1 synthesis, monocyte adhesion, and CD206 expression (Fig. 3C-E and 4C-E). The gene discussed is SRC; the disease is osteosarcoma.